Metraipolis › archive › dc_faefc1432226
Conversion TORS after neoadjuvant immunotherapy for advanced BOT-SCC: a retrospective study — Europe PMC PMID:41568389
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41568389
- DOI
- 10.3389/fonc.2025.1709974
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T01:02:21.225Z
- SHA-256 of the archived text
45df248a329199bc313b13baa7d61cf4743a5923b16eda9cfe3bc8f79bd398c7- Stable URL of this page
https://metraipolis.com/documento/dc_faefc1432226
How to cite
Conversion TORS after neoadjuvant immunotherapy for advanced BOT-SCC: a retrospective study — Europe PMC PMID:41568389 — Europe PMC (en), https://europepmc.org/article/MED/41568389 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_faefc1432226 (Metraipolis archive dc_faefc1432226, sha256 45df248a329199bc313b13baa7d61cf4743a5923b16eda9cfe3bc8f79bd398c7)
BibTeX
@misc{dcfaefc1432226,
title = {Conversion TORS after neoadjuvant immunotherapy for advanced BOT-SCC: a retrospective study — Europe PMC PMID:41568389},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41568389},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_faefc1432226; sha256 45df248a329199bc313b13baa7d61cf4743a5923b16eda9cfe3bc8f79bd398c7},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41568389. Agents can read the archived copy with the MCP tool read_document.